Combined Use of Bendamustine, Doxorubicin and Bortezomib for the Treatment of Multiple Myeloma
申请人:Farag Sherif S.
公开号:US20110217258A1
公开(公告)日:2011-09-08
Methods for treating multiple myeloma by administering a combination of a proteasome inhibitor, bendamustine and doxorubicin are described.